|
pubmed:abstractText |
Depressive disorders are common in young people and are associated with significant negative impacts. Selective serotonin reuptake inhibitors (SSRIs) are often used, however, evidence of their effectiveness in children and adolescents is not clear. Furthermore, there have been warnings against their use in this population due to concerns about increased risk of suicidal ideation and behaviour.
|
|
pubmed:affiliation |
ORYGEN Research Centre, Department of Psychiatry, University of Melbourne, Locked Bag 10, 35 Poplar Road, Parkville, Melbourne, Victoria, Australia, 3054. shetrick@unimelb.edu.au
|
